Paras Healthcare IPO Day 2: 0.36x subscribed; Overall retail portion at 2.10x

Key takeaways:
- The Paras Healthcare IPO is a book-built offering of ₹1,450 crore, which includes a fresh issue of ₹500 crore and an offer for sale (OFS) of ₹950 crore.
- The bidding window opened on Wednesday, October 21, 2026, and will remain open for 3 days until Friday, October 23, 2026.
- Paras Healthcare is a Gurugram-based hospital operator with eight hospitals and 2,211 beds across North and East India.
- As of Day 2, the IPO was subscribed 0.36 times overall, up from 0.15 times at the end of Day 1. The retail portion was subscribed 1.37 times.
Paras Healthcare IPO Day 2 saw retail investors take the lead, with total subscription reaching 0.36 times as of the end of the Day 2 bidding session. This IPO is a book-built initial public offering (IPO) of ₹1,450 crore. The IPO comprises a fresh issue of ₹500 crore (about 72.15 lakh shares) and an offer for sale (OFS) of ₹950 crore (about 1.37 crore shares). The OFS proceeds will go to the selling shareholders, not to the company.
The proceeds from the fresh issue will be used to repay borrowings (₹320.90 crore), to invest ₹54.10 crore in wholly owned subsidiary PMHPL so that it can repay its own borrowings, and for general corporate purposes. Let's take a closer look at the Paras Healthcare IPO Day 2 details.
Key details of Paras Healthcare IPO
Some key insights that investors should know about the Paras Healthcare IPO are mentioned below:
Key dates for the Paras Healthcare IPO
The Paras Healthcare IPO is currently in its subscription phase. Here are the key dates related to the IPO.
About Paras Healthcare
Paras Healthcare Limited is a leading clinical specialty hospital platform. It operates eight hospitals in Gurugram, Panchkula, Patna, Kanpur, Udaipur, Ranchi, Darbhanga, and Srinagar, with a combined capacity of 2,211 beds, over 1,000 doctors and around 1,900 nurses.
The hospital chain focuses heavily on clinical specialties including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences (CONGOR), which collectively contributed 75.30% of its revenue in FY26.
The company has turned from losses to profits, as it has posted PAT of 43.83 crore in FY26 after two consecutive years of losses of ₹15.33 crore in FY24 and ₹57.98 crore in FY25.
Subscription status on Day 2
The cumulative subscription till the end of Day 2 reached 0.51 times, building on the 0.15 times at the end of Day 1. Here are the subscription details for the first 2 days:
What is next?
Market analysts attribute the steady retail oversubscription on Day 2 to Paras Healthcare's established asset footprint in Tier 2 and Tier 3 North Indian cities, its strong Q1 FY27 profitability, and the balance-sheet relief expected from ₹375 crore in planned debt repayment.
But some investors are cautious because of the massive offer for sale (OFS) portion, the debt of ₹1,393.86 crore as of March 2026 and the liquidity competition from the simultaneous mega-IPO of Jio Platforms.
As the subscription window heads into its last subscription day tomorrow (Friday, October 23, 2026), the spotlight rests on institutional and HNI bidders to determine the final subscription tally ahead of Monday's allotment finalisation.












